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Background-—Fatty acids constitute the critical components of cell structure and function, and dysregulation of fatty acid
composition may exert diverging vascular effects including proliferation, migration, and differentiation of vascular smooth muscle
cells (VSMCs). However, direct evidence for this hypothesis has been lacking. We investigated the role of elongation of long-chain
fatty acid member 6 (Elovl6), a rate-limiting enzyme catalyzing the elongation of saturated and monounsaturated long-chain fatty
acid, in the regulation of phenotypic switching of VSMC.
Methods and Results-—Neointima formation following wire injury was markedly inhibited in Elovl6-null (Elovl6/) mice, and
cultured VSMCs with siRNA-mediated knockdown of Elovl6 was barely responsive to PDGF-BB. Elovl6 inhibition induced cell cycle
suppressors p53 and p21 and reduced the mammalian targets of rapamycin (mTOR) phosphorylation and VSMC marker
expression. These changes are ascribed to increased palmitate levels and reduced oleate levels, changes that lead to reactive
oxygen species (ROS) production and resulting AMP-activated protein kinase (AMPK) activation. Notably, Elovl6 inhibition robustly
induced the pluripotency gene Kr€uppel-like factor 4 (KLF4) expression in VSMC, and KLF4 knockdown signiﬁcantly attenuated
AMPK-induced phenotypic switching of VSMC, indicating that KLF4 is a bona ﬁde target of AMPK.
Conclusions-—We demonstrate for the ﬁrst time that dysregulation of Elovl6-driven long-chain fatty acid metabolism induces
phenotypic switching of VSMC via ROS production and AMPK/KLF4 signaling that leads to growth arrest and downregulation of
VSMC marker expression. The modulation of Elovl6-mediated cellular processes may provide an intriguing approach for tackling
atherosclerosis and postangioplasty restenosis. ( J Am Heart Assoc. 2016;5:e004014 doi: 10.1161/JAHA.116.004014)
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P henotypic modulation of vascular smooth muscle cells(VSMCs) is a critical process that regulates the progres-
sion of proliferative vascular disease including atherosclerosis
and postangioplasty restenosis.1-4 There have been extensive
studies demonstrating that various growth factors, such as
platelet-derived growth factor (PDGF) and ﬁbroblast growth
factor-2, promote phenotypic switching characterized by the
downregulation of expression of differentiation marker genes
such as smoothmuscle a-actin (SMa-actin) and smoothmuscle
myosin heavy chain and the induction of proliferative capacity
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and proinﬂammatory gene expression.2,5 There is now evidence
that a signiﬁcant fraction of VSMC within atherosclerotic
plaques and cholesterol-loaded cultured VSMC express mark-
ers of macrophages and mesenchymal stem cells as well as
myoﬁbroblasts.6-8 These ﬁndings argue that phenotypic switch-
ing of VSMC is more dynamically regulated than previously
noted, and altered lipid metabolism within VSMC markedly
contributes to phenotypic transitions of VSMC.
Elongation and desaturation are central steps in the de novo
synthesis of long-chain fatty acids (LCFAs) that determine their
function and metabolic fate. The elongation of LCFA family
member 6 (Elovl6) is by a rate-limiting enzyme thatmediates the
elongation reaction of palmitate (C16:0) to stearate (C18:0),
and stearoyl-CoA desaturase (SCD) catalyzes the conversion of
stearate to oleate (C18:1 n-9).9 Mice deﬁcient in Elovl6
(Elovl6/) are protected against diet-induced insulin resis-
tance despite their hepatosteatosis and obesity being similar to
that in wild-type (WT) mice.10 Amore recent study reported that
an atherogenic high-fat diet induced hepatic inﬂammation,
oxidative damage, and ﬁbrosis in the liver, the hallmark features
of nonalcoholic steatosis (NASH),11 but these were attenuated
in Elovl6/ mice. Furthermore, Elovl6 deﬁciency in macro-
phages ameliorated foam cell formation.12 We previously
demonstrated that Elovl6 inhibition in alveolar type II epithelial
cells leads to severe pulmonary ﬁbrosis.13 These ﬁndings
suggest that Elovl6-driven LCFA metabolism regulates a
plethora of cellular function. However, VSMC phenotype in
Elovl6/ mice remains unknown.
In the present study we investigated the effects of Elovl6
deﬁciency on VSMC phenotype in Elovl6/ mice and in
cultured human aortic smooth muscle cells (HASMC) with
small interfering RNA (siRNA)-mediated Elovl6 knockdown.
Our ﬁndings reveal that Elovl6 inhibition exerts profound
effects on VSMC phenotype through an activation of AMP-
activated protein kinase (AMPK)/Kr€uppel-like factor 4 (KLF4)
signaling and strongly suggest a previously unrecognized
mechanistic link between intracellular LCFA composition and
VSMC phenotype.
Methods
Animal Model
C57BL/6 strain (WT) mice and Wistar rats were purchased
from CLEA Japan Inc. Elovl6/ mice were a kind gift from Dr
H. Shimano (Tsukuba University). These mice were inter-
crossed into Elovl6/ or Elovl6/+ mice. Littermates were
genotyped by PCR. The femoral artery of 10- to 12-week-old
male WT mice (n=24, 24-28 g) and Elovl6/ mice (n=23, 22-
26 g) was injured with a wire, as previously described,14 with
some modiﬁcations.15 Brieﬂy, a straight spring wire (0.38 mm
in diameter, Cook Medical, Bloomington, IN) was inserted into
the right femoral artery and pushed forward toward the iliac
artery. The wire was left in place for 1 minute to denude and
dilate the artery and then was removed. Blood ﬂow was
reconstituted after ligation of the profunda femoris branch.
Mice were sacriﬁced 14 days after this injury, and the femoral
arteries were isolated. Uninjured femoral arteries were
isolated from sham controls. The carotid artery of rats was
injured with a balloon as described previously.16 See Data S1
for further details. Animal experiments using these mice were
approved by and performed according to the guidelines of the
Committee of Experimental Animal Research of Gunma
University (Permit Number: 10-019).
Cell Culture
VSMCs from the human aorta (HASMC) were purchased from
Kurabo Ltd (New York, NY). See Data S1 for further details.
RNA Isolation and Quantitative Real-Time
Reverse Transcription (qRT-PCR)
Total RNA was extracted from the mouse aorta and cultured
HASMC using ISOGEN regent (Takara Bio, Shiga, Japan)
according to the manufacturer’s protocol. See Data S1
for further details. All primer sequences are shown in Tables
S1 and S2.
Recombinant Adenovirus
Adenoviruses expressing LacZ (Ad-LacZ) or Elovl6 (Ad-Elovl6)
were generated as described previously.17 HASMC were
infected with Ad-Elovl6 or Ad-LacZ at a multiplicity of infection
of 20 for 48 hours in preparation for the next experiments.
Elongase Activity
Microsomal fatty acid elongation activity was assayed by
measuring the incorporation of [2-14C]malonyl-CoA (Perkin
Elmer, Shelton, CT) into exogenous acyl-CoAs as described
previously.10,13
[3H]Thymidine Uptake
The uptake of radiolabeled [3H]thymidine (Perkin Elmer,
Shelton, CT) was assayed as described previously,18 with
some modiﬁcations. See Data S1 for further details.
Scratch Wound Healing Assay
The measurement of migration by the scratch mobility assay
was performed as described previously.19 See Data S1 for
further details.
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Boyden Chamber Assay
The Boyden chamber assay was performed as previously
described.19 See Data S1 for further details.
Fatty Acid Composition
Lipids from the mouse aorta and HASMC were extracted using
the Bligh and Dyer method as described previously.20 See
Data S1 for further details.
Quantitation of ROS Measurement
For the quantitation of ROS levels, we used Hydrogen
Peroxide/Peroxidase Assay Kit, Fluorometric (Cell Biolabs,
San Diego, CA) according to the manufacturer’s protocol. Red
ﬂuorescence (excitation 550 nm; emission 590 nm) was
detected by microplate reader (Perkin Elmer, EnSpire, Shel-
ton, CT).
Statistical Analysis
All data are shown as the meanstandard error of the mean
(SEM). A 2-group comparison was performed using the Mann-
Whitney U-test or unpaired Student t test, and a multiple-
group comparison was performed by a 1-way ANOVA with
Steel-Dwass or Tukey-Kramer multiple comparison tests. A
P<0.05 was considered signiﬁcant.
Results
Elovl6 Expression in Neointimal VSMC in
Uninjured and Injured Femoral Artery in
Wild-Type Mice
A mouse wire-injury model, in which a straight spring wire was
inserted into the femoral artery to denude and dilate the artery,
was used in the present study. Immunohistochemistry revealed
modest but discernible staining for Elovl6 in the medial layer of
the uninjured femoral artery inWTmice. In contrast, the femoral
artery 14 days after wire injury showed prominent positive
staining for Elovl6 in the hypertrophic neointimal layer, in which
SMa-actin-positive cells accumulated. Elovl6 staining was only
modestly detected in the tunica media but was clearly detected
in perivascular adipose tissue (Figure 1A).
Mice Deﬁcient in Elovl6 Display Reduced
Neointima Formation After Vascular Injury
The femoral artery of Elovl6/ mice was subjected to wire
injury to compare the neointima formation between WT and
Elovl6/ mice. Hematoxylin-eosin (H&E) and elastica van
Gieson (EVG) staining showed that the thickness of the medial
layer of uninjured femoral artery appeared thinner in Elovl6/
mice compared with that in WT mice. Immunohistochemistry
revealed that neointima formation was markedly inhibited in
Elovl6/ mice compared to WT mice, as assessed by H&E
and EVG (Figure 1A). In addition, the semiquantitative intima/
media (I/M) ratio and percentage stenosis assessment
demonstrated that I/M ratio and percentage stenosis were
signiﬁcantly lower in Elovl6/ mice than in WT mice
(Figure 1B). Furthermore, immunoﬂuorescent Ki-67 staining,
a cell proliferation marker,21 showed that neointima of
Elovl6/ mice had signiﬁcantly fewer cells positive for Ki-
67 than a similar region in WT mice (Figure 1C). These results
suggested that the knockout of Elovl6 inhibits neointima
formation by repressing VSMC proliferation.
Immunohistochemistry of a rat carotid subjected to balloon
injury conﬁrmed the induction of Elovl6 expression in
neointimal VSMC (Figure 1D). We also examined the expres-
sion of Elovl6 in the human coronary artery obtained by
autopsy. Distinct immunoreactivity for Elovl6 was detected in
the medial layer and diffuse intimal thickening area, in which
SMa-actin appears to be more strongly expressed (Figure S1).
Elovl6 Knockdown Reduces VSMC Proliferation
and Migration
To examine the role of Elovl6 in the regulation of VSMC
proliferation and migration, Elovl6 was silenced by siRNA in
cultured HASMC. We ﬁrst veriﬁed that Elovl6 mRNA expres-
sion was efﬁciently downregulated (<1% of control si green
ﬂuorescent protein [GFP]-transfected cell, P<0.01) as
assessed by qRT-PCR, and elongase activity was reduced to
66% compared with GFP siRNA (siGFP)-transfected cells
(P<0.05) (Figure 2A). We then examined the effects of Elovl6
knockdown on DNA synthesis by using [3H]thymidine incor-
poration assay. In Elovl6 siRNA (siElovl6)-transfected HASMC,
the incorporation of [3H]thymidine was markedly reduced
compared with that in siGFP-transfected control HASMC
(Figure 2B). In order to conﬁrm these results, we generated
an adenovirus expressing Elovl6 (Ad-Elovl6) (Figure S2). The
results obtained showed that the overexpression of Elovl6
increased the incorporation of [3H]thymidine to a similar
extent as PDGF-BB treatment (Figure 2B). PDGF-BB-induced
incorporation as well as baseline levels of [3H]thymidine
incorporation were markedly diminished in siElovl6-trans-
fected HASMC (Figure 2B). These results suggested that
Elovl6 had a marked impact on VSMC proliferation at baseline
and played an indispensable role in mitogenic response
elicited by PDGF-BB. Together with the induction of Elovl6
gene expression by PDGF-BB (Figure S3), these results
suggested that Elovl6-mediated fatty acid metabolism serves
an intracellular cue for the proliferative response of VSMC to
PDGF-BB stimulation. Effects of Elovl6 on VSMC migration
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were examined using scratch wound healing assay. Inhibition
of Elovl6 in HASMC resulted in a signiﬁcant decrease in
migration activity as determined by Boyden chamber assay
(Figure 2C).
Knockdown or Overexpression of Elovl6 Affects
VSMC Marker Gene Expression
Because proliferation, migration, and differentiation are
orchestrated through a shared cellular program, we
determined whether Elovl6 was also involved in VSMC
differentiation. We found that siRNA-mediated knockdown of
Elovl6 in cultured HASMC and the disruption of the Elovl6
gene in mice reduced mRNA and protein expression levels of
the SMa-actin and smooth muscle protein 22-a (SM22a)
genes, well deﬁned VSMC markers (Figure 2D and 2E), while
b-actin protein levels were decreased. Such a decrease in
b-actin protein levels is probably due to the suppression of
mTOR activity (see below) because the AMPK/mTOR pathway
is known to regulate the expression of the genes relevant to
Figure 1. Neointimal hyperplasia after mechanical vascular injury is reduced in Elovl6/ mice. A,
Representative section of H&E staining, EVG staining, and immunohistochemical staining with Elovl6
and SMa-actin antibodies in mouse femoral artery 14 days after wire injury. The femoral arteries of 10-
to 12-week-old male WT mice and Elovl6/ mice were injured with a wire. The expression of Elovl6
was colocalized with SMa-actin-positive cells in WT mice. The inhibition of neointimal hyperplasia was
signiﬁcantly greater in Elovl6/ mice than in WT mice. Scale bar=200 lm. B, The I/M ratio (left) and
percentage stenosis area (right) were signiﬁcantly lower in Elovl6/ mice (n=9) than in WT mice
(n=10). C, Representative immunoﬂuorescence staining with a Ki-67 antibody (red) and DAPI (blue),
and the number of Ki-67-positive cells per high-power ﬁeld in wire-injured artery sections. The number
of Ki-67-positive cells was markedly lower in Elovl6/ mice (n=9) than in WT mice (n=10). Scale
bar=200 lm. D, Representative sections with H&E staining, EVG staining, and immunohistochemical
staining with Elovl6 and SMa-actin antibodies in the rat carotid artery subjected to balloon injury.
Eight-week-old male Wistar rats were injured with a 2F balloon catheter. The expression of Elovl6 was
colocalized with SMa-actin-positive cells in the uninjured WT rat carotid, and increased in the
neointimal area of the balloon-injured rat carotid. Scale bar=200 lm. All values are represented as the
means. *P<0.05, measured by the Mann-Whitney U-test (B) or the Student t test (C). DAPI indicates
40,6-diamidino-2-phenylindole; Elovl6, elongation of long-chain fatty acid family member 6; EVG,
elastica van Gieson; H&E, hematoxylin-eosin; I/M, intima/media; SMa-actin, smooth muscle a-actin;
WT, wild-type C57BL/6.
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cellular proliferation.22 In contrast, the adenovirus-mediated
overexpression of Elovl6 increased the expression of these
genes (Figure S4A and S4B) in HASMC, suggesting that
Elovl6-driven fatty acid metabolism plays an important role in
the regulation of VSMC differentiation.
Elovl6 Regulates Cell Cycle Inhibitory Gene and
Protein Expression
To determine the mechanisms by which Elovl6 knockdown
reduces VSMC proliferation, we examined the expression of
mRNAs and proteins critical for cell proliferation in HASMC
transfected with either siElovl6 or siGFP. The results obtained
showed that knockdown of Elovl6 increased the p53 expres-
sion by 1.2-fold and p21 expression by 2.0-fold and decreased
the mRNA levels of mammalian target of rapamycin (mTOR), a
serine/threonine protein kinase that phosphorylates the
binding protein essential for translational initiation and
protein synthesis, by 45% (Figure 3A). Consistent with these
results, the mRNA levels of p53 and p21 in the aorta were
1.3- and 2.9-fold higher, respectively, while those of mTOR
were comparable between Elovl6/ and WT mouse aorta
(Figure 3A). Knockdown of Elovl6 induced the phosphoryla-
tion of p53 tumor suppressor and protein expression of cyclin-
dependent kinase inhibitor p21 (Figure 3B). An increase in the
expression of p21 is likely due to the activation of p53 given
that the p21 gene is a direct target of p53.23 The phospho-
rylation of mTOR was clearly decreased in siElovl6-transfected
HASMC (Figure 3B).
Conversely, the overexpression of Elovl6 increased mTOR
mRNA levels (Figure S4C). To further analyze the role of p21
in HASMC with silenced Elovl6, siRNA for p21 was transfected
with or without siRNA for Elovl6, and the effects of the
silencing of p21 on thymidine uptake were evaluated. The p21
siRNA treatment resulted in an increase in the uptake of
thymidine, and, more importantly, the repressed thymidine
uptake in cells with Elovl6 knockdown was completely
reversed by p21 siRNA treatment (Figure 3C). These results
indicate that the Elovl6 knockdown reduces cell proliferation
largely through the induction of p21 expression.
Elovl6 Deﬁciency Induces AMPK Activity in VSMC
AMP-activated protein kinase (AMPK), a heterotrimeric ser-
ine/threonine protein kinase that is primarily activated in
response to nutrients and energetic stress,24-26 has been
shown to regulate cell proliferation via a p53 and p21 pathway
in response to vascular injury.27,28 To explore the effects of
Elovl6 deﬁciency on AMPK activation, we performed Western
blot analysis by using the antibody against phosphopeptides
Figure 1. continued
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containing Thr-172 of the a subunit of human AMPK. Results
showed that knockdown of Elovl6 markedly induced the
phosphorylation of AMPK in HASMC and that the total protein
levels of AMPK were comparable between siGFP- and siElovl6-
transfected cells. The p21 protein levels were increased while
b-actin protein levels were decreased (Figure 3B). Consis-
tently, Elovl6/ mice exhibited signiﬁcantly increased phos-
phorylated AMPK levels and slightly decreased b-actin levels
compared to WT mice (Figure 3D). In contrast, the
overexpression of Elovl6 decreased phosphorylation of AMPK
(Figure S4D).
AMPK activation has been shown to mediate an increase in
fatty acid oxidation via acetyl-CoA carboxylase (ACC) phos-
phorylation at Ser-78, which leads to inactivation of ACC
activity and reduction of malonyl-CoA synthesis, in the setting
of metabolic stress.29 We found that ACC phosphorylation is
associated with AMPK activation in HASMC with Elovl6
knockdown (Figure 3B), providing evidence that AMPK activity
Figure 2. Inhibition of Elovl6 gene expression suppresses VSMC proliferation and migration. A, qRT-PCR
for Elovl6 mRNA expression and Elovl6 enzymatic activity in HASMC transfected with Elovl6 (n=6) or GFP
siRNA (n=6). Elovl6 siRNA suppressed Elovl6 mRNA expression and activity more strongly than GFP siRNA.
Speciﬁc activity was expressed as picomoles of radioactive [2-14C]malonyl-CoA incorporated into
hydrophobic long-chain fatty acid fractions by 1 mg of microsomal protein. B, The [3H]thymidine uptake
assay in HASMC transfected with Elovl6 (n=6) or GFP siRNA (n=6), or adenovirus-mediated overexpression
of Elovl6 (n=6) or LacZ (n=6). The knockdown of Elovl6 expression markedly suppressed the incorporation
of [3H]thymidine, whereas its overexpression induced the uptake of [3H]thymidine signiﬁcantly more than
the PDGF-BB treatment (10 ng/mL, n=6) for 24 hours. The PDGF-BB-induced incorporation of [3H]
thymidine was canceled by the siRNA-mediated knockdown of Elovl6. C, Scratch assay and Boyden
chamber assay in HASMC transfected with Elovl6 (n=6) or GFP siRNA (n=7). The knockdown of Elovl6
markedly suppressed cell migration. The number of migrated cells was counted under a light microscope.
Scale bar=200 lm. D and E, qRT-PCR for SMa-actin and SM22a mRNA expression (D) and Western blot for
protein expression (E) in HASMC transfected with Elovl6 (n=6) or GFP siRNA (n=6) and in the aorta of
Elovl6/ mice (n=6) or WT mice (n=6). The mRNA levels of SMa-actin and SM22a assessed by qRT-PCR,
normalized by mRNA levels of the nuclear single-copy housekeeping gene 36B4, were signiﬁcantly
decreased by siRNA-mediated knockdown of Elovl6 or in Elovl6/ mouse aorta. The levels of protein
expression for SMa-actin and SM22a were normalized by b-actin. Each experiment was performed at least
3 times. All values are represented as the meansSEM of 3 experiments. *P<0.05, **P<0.01, as measured
by the Mann-Whitney U-test, Student t test, or Tukey-Kramer test. Elovl6 indicates elongation of long-chain
fatty acid family member 6; HASMC, human aortic smooth muscle cells; PDGF-BB, platelet-derived growth
factor-BB; SMa-actin, smooth muscle a-actin; SM22a, smooth muscle protein 22a; WT, wild-type C57BL/6
mice.
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is indeed increased in these cells. Because inhibition of ACC
and subsequent decrease in malonyl-CoA production lead to a
suppression of lipogenesis and favor fatty acid oxidation
through an induction of carnityl palmitoyltransferase (CPT)
shuttle system,30 it is likely that Elovl6-deﬁcient VSMC has
reduced synthesis and increased oxidation of LCFA. As
expected, FA oxidation rate, as assessed by using [14C]-
palmitic acid, was higher in VSMC transfected with siElovl6 in
comparison with siGFP-transfected VSMC. Furthermore, the
mRNA levels of peroxisome proliferator-activated receptor
(PPAR)a, the nuclear receptor playing a crucial role as an
activator of genes involved in fatty acid oxidation,31 were
increased in HASMC with Elovl6 knockdown as compared
with siGFP-transfected cells (data not shown).
Elovl6 Knockdown Alters LCFA Composition in
VSMC In Vivo and In Vitro
To determine the effect of Elovl6 knockdown on LCFA
metabolism, we examined the composition of LCFA in lipids
extracted from the aorta of Elovl6/ and WT mice. Saturated
palmitate (C16:0) levels were higher, and monounsaturated
oleate (C18:1 n-9) levels were lower in Elovl6/ mice than in
WT mice (Figure 4A). The qRT-PCR revealed that the aortic
expression of the gene for SCD1, a rate-limiting enzyme that
converts saturated fatty acids (SFAs) to monounsaturated
fatty acids, was lower in Elovl6/ mice than in WT mice
(Figure 4B) (60% of the control value, P<0.05).
Alterations of the composition of LCFA and reductions of
the expression of SCD1 in the aorta of Elovl6/ mice were
recapitulated by Elovl6 siRNA treatment in vitro (Figure 4C
and 4D). These results also indicate that metabolic phenotype
such as a lower oleate (C18:1 n-9) levels with an Elovl6
knockdown may be partially due to a decrease in SCD1
activity. In contrast, the overexpression of Elovl6 in HASMC
decreased palmitate and palmitoleate (C16:1 n-7) levels and
increased oleate levels (Figure S5A), whereas the mRNA levels
of SCD1 were similar in HASMC transduced with Ad-Elovl6 or
Ad-LacZ (Figure S5B). Taken together, these results indicate
that Elovl6 in VSMC plays a major role in determining the fatty
acid composition of LCFA in VSMC.
Effects of Palmitate and Oleate on Cell
Proliferation and Cell Cycle Regulators
Given the data presented above, we examined the effects of
palmitate and oleate on VSMC proliferation and cell cycle
regulatory gene expression. Palmitate treatment reduced the
incorporation of [3H]thymidine by 30% (P<0.05), whereas
oleate treatment increased it by 20% (P<0.01) (Figure 5A).
The qRT-PCR analysis also revealed that palmitate suppressed
the SMa-actin (72%, P<0.05), SM22a (56%, P<0.05), p53 (1.4-
fold, P<0.01), and p21 (1.8-fold, P<0.01) mRNA levels,
whereas oleate increased the mTOR mRNA levels (1.6-fold,
P<0.01) (Figure 5B). Western blot analysis also showed that
palmitate treatment decreased protein levels of SMa-actin
and SM22a (Figure 5C). Furthermore, palmitate treatment
signiﬁcantly induced the phosphorylation of AMPK, ACC, and
p53, increased the expression of p21, and decreased the
phosphorylation of mTOR (Figure 5D). In contrast, oleate
Figure 2. continued
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treatment decreased total protein levels of AMPK, ACC, and
p53 and p21, and increased total mTOR levels, as previously
reported,32-35 and as such, levels of phosphorylated form of
AMPK, ACC, and p53 were decreased, and levels of
phosphorylated form of mTOR were increased (Figure 5D). A
simultaneous stimulation with palmitate and oleate consis-
tently showed that each of these 2 LCFAs antagonizes the
effects of the other (Figure 5A through 5D).
Figure 3. Depletion of Elovl6 expression modulates cell cycle regulators in HASMC. A, qRT-PCR for p53,
p21, and mTOR mRNA expression in HASMC transfected with Elovl6 (n=6) or GFP siRNA (n=8) and in the
aorta of Elovl6/ mice (n=6) or WT mice (n=6). The expression levels of p53 and p21 mRNA, normalized
by mRNA levels of 36B4, were signiﬁcantly induced while that of mTOR mRNA was signiﬁcantly decreased
by siRNA-mediated knockdown of Elovl6 or in the Elovl6/ mice aorta. B, Western blot analysis of each
protein level involved in cell proliferation in HASMC. Protein levels were normalized by b-actin. The
knockdown of Elovl6 (n=5) signiﬁcantly induced the phosphorylation of AMPK, ACC, and p53 and
expression of p21 but reduced the phosphorylation of mTOR more than that in the siGFP-transfected
control cells (n=7). C, Effects of p21 gene silencing on the antiproliferative effects of the knockdown of
Elovl6 in HASMC. Elovl6 siRNA-mediated antiproliferative effects were canceled by p21 depletion (siGFP,
siElovl6, sip21: n=6; siElovl6+sip21: n=5). D, Western blot analysis of the aorta of Elovl6/ mice (n=6) or
WT mice (n=6). The phosphorylation of AMPK in the aorta was markedly increased in Elovl6/ mice
compared to WT mice. Western blot data for phosphorylation of proteins were normalized by total proteins
in the same samples and expressed as a fold increase from the mean level of siGFP or the WT mice. Each
experiment was performed at least 3 times. All values are represented as the meansSEM of 3
experiments. *P<0.05, **P<0.01, as measured by the Mann-Whitney U-test (A, B, and D) or the Tukey-
Kramer test (C). ACC indicates acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; Elovl6,
elongation of long-chain fatty acid family member 6; HASMC, human aortic smooth muscle cells; mTOR,
mammalian target of rapamycin; WT, wild-type C57BL/6 mice.
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Elovl6 Knockdown Induces KLF4 Expression in
VSMC
Kr€uppel-like factor 4 (KLF4), a reprogramming factor that
promotes induced pluripotent stem (iPS) cell formation,36
controls the expression of VSMC marker genes.37,38 KLF4
induces the expression of p21 in concert with the activation of
p53 and as a result decreases the proliferation of VSMC.38 We
performed a series of experiments to test whether KLF4 is
involved in the suppression of proliferation of Elovl6 siRNA-
transfected HASMC. Immunohistochemistry revealed that
KLF4 expression was more evident in Elovl6/ mice than in
WT mice in both uninjured and wire-injured aorta (Figure 6A).
Western blot and qRT-PCR analyses using protein and RNA
extracts from aorta, respectively, conﬁrmed these ﬁndings
(Figure 6B). In addition, Elovl6 knockdown led to a robust
elevation in KLF4 expression at both protein and mRNA levels
(Figure S6A and S6B). Overexpression of Elovl6 suppressed the
KLF4 protein and mRNA levels (Figure S6C and S6D),
substantiating the above ﬁndings. Of note, exogenous palmi-
tate signiﬁcantly upregulated KLF4 protein and mRNA levels,
and oleate blunted these effects (Figure 6C and Figure S6E),
further supporting the ﬁndings that KLF4 expression is
regulated by Elovl6-driven fatty acid metabolism.
KLF4 Knockdown Mitigates Upregulation of p53
and p21 in Elovl6-Deﬁcient VSMC
We next examined the cell cycle regulatory gene expression
and cell proliferation in HASMC with Elovl6 knockdown.
Figure 4. Elovl6 depletion modulates fatty acid composition in vivo and in vitro. A and B, Fatty acid
composition of a lipid extract (A) and qRT-PCR for SCD1 gene expression (B) from the aorta of Elovl6/
(n=5) or WT mice (n=4). The relative amounts of palmitate (C16:0) were higher, whereas those of oleate
(C18:1 n-9) were lower in Elovl6/ mice than in WT mice (A). SCD1 mRNA levels, normalized by mRNA
levels of 36B4, were lower in Elovl6/ mice (n=5) than in WT mice (n=4) (B). C and D, Fatty acid
composition of a neutral lipid extract (C) and qRT-PCR for SCD1 gene expression (D) in HASMC transfected
with Elovl6 (n=5) or GFP siRNA (n=6). Along with in vivo data, the relative amounts of palmitate were
signiﬁcantly higher, whereas those of oleate (C) and SCD1 mRNA levels, normalized by mRNA levels of
36B4 (D), were lower with the knockdown of Elovl6 than with siGFP transfection. mRNAs of the WT mice (B)
and siGFP (D) control group were normalized to a value of 1, and mRNA levels in Elovl6/ mice or Elovl6
siRNA cells are shown relative to the control level. Each experiment was performed at least 3 times. All
values are represented as the meansSEM of 3 experiments. *P<0.05, **P<0.01, as measured by the
Mann-Whitney U-test. Elovl6 indicates elongation of long-chain fatty acid family member 6; HASMC, human
aortic smooth muscle cells; SCD1, stearoyl-CoA desaturase 1; WT, wild-type C57BL/6 mice.
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After conﬁrming substantial depletion of KLF4 (Figure S7A
and S7B), we performed qRT-PCR analysis. Simultaneous
knockdown of KLF4 partly rescued the suppressed
proliferation in siElovl6-transfected HASMC (Figure S7C).
Consistent with these results, knockdown of KLF4 abro-
gated the increase in phospho-p53 and p21 protein levels
Figure 5. Palmitate suppresses cell proliferation by altering cell cycle regulatory proteins in HASMC. A,
[3H]Thymidine uptake assay in HASMC treated with PA or OA. PA (250 lmol/L) treatment signiﬁcantly
suppressed, whereas OA (250 lmol/L) treatment induced, the incorporation of [3H]thymidine (BSA, OA:
n=6; PA: n=8). Simultaneous treatment with OA signiﬁcantly inhibited PA-induced antiproliferative effects
(PA+OA: n=6). B, qRT-PCR for SMa-actin, SM22a, p53, p21, and mTOR mRNA levels, normalized by mRNA
levels of 36B4, in HASMC treated with PA or OA (BSA: n=7; PA, OA, PA+OA: n=6). The mRNA levels for
SMa-actin and SM22a were signiﬁcantly decreased, whereas that of p21 and p53 mRNA levels were
increased by PA treatment. In contrast, mTOR mRNA levels were signiﬁcantly increased by OA treatment.
mRNA levels in the siGFP control group were normalized to a value of 1, and those in cells treated with
various stimuli are shown relative to the control level. C and D, Western blot analysis of each protein level
involved in cell proliferation in HASMC treated with PA or OA (BSA: n=8; PA, OA, PA+OA: n=6). PA markedly
induced the phosphorylation of AMPK, ACC, and p53 and expression of p21, whereas OA induced the
phosphorylation of mTOR. Simultaneous treatment with PA and OA mutually suppressed the induction of
protein expression. Furthermore, treatment of PA decreased SMa-actin and SM22a protein expression.
Western blot data for phosphorylation of proteins were normalized by total protein amount in the same
samples and expressed as a fold increase from the mean level of the BSA group; p21 protein levels were
normalized by b-actin protein levels. Each experiment was performed at least 3 times. All values are
represented as the meansSEM of 3 experiments. *P<0.05, **P<0.01, as measured by the Tukey-Kramer
test (A and B) or the Steel-Dwass test (C and D). ACC indicates acetyl-CoA carboxylase; AMPK, AMP-
activated protein kinase; BSA, fatty acid-free bovine serum albumin; HASMC, human aortic smooth muscle
cells; mTOR, mammalian target of rapamycin; OA, oleic acid; PA, palmitic acid; SM22a, smooth muscle
protein 22a; SMa-actin, smooth muscle a-actin.
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Figure 6. Elovl6 deﬁciency directly induces KLF4 expression through AMPK activation. A, Immunohistochem-
ical staining with an anti-KLF4 antibody in femoral artery sections from Elovl6/ or WT mice. Expression of
KLF4 was signiﬁcantly increased in the medial layer of the aorta of Elovl6/ mice compared to WT mice
before or after wire injury. Scale bar=200 lm. B, Western blot and qRT-PCR analyses of KLF4 expression in the
aorta of Elovl6/ mice (n=6). KLF4 expression was signiﬁcantly induced in the Elovl6/ mice aorta
compared to WT mice (n=6). C, Western blot analysis of KLF4 in HASMC treated with PA or OA. KLF4 was
signiﬁcantly increased by PA treatment but decreased by OA treatment (BSA, PA: n=8; OA, PA+OA: n=6). D,
Effects of KLF4 gene silencing on Elovl6 siRNA-induced cell cycle regulatory proteins in HASMC by Western
blot analysis. Elovl6 siRNA-induced phospho-p53 or p21 protein levels were suppressed by the depletion of
KLF4 (siGFP, siElovl6, siGFP, or siElovl6+siKLF4: n=6). E, Western blot analysis of AICAR (1 mmol/L, n=6) and
Compound C (10 lmol/L, n=6) stimulations in HASMC. Treatment of AICAR induced the KLF4 expression in a
time-dependent manner, but costimulation with Compound C (n=6) reduced the AICAR-induced expression of
KLF4. F, Western blot analysis of KLF4 in GFP siRNA (n=5)- or Elovl6-siRNA (n=6)-transfected HASMC with or
without Compound C. Compound C abrogated the Elovl6 siRNA-induced expression of KLF4. The mRNA levels
determined by qRT-PCR were normalized by 36B4, and protein levels determined by Western blot analysis were
normalized by b-actin levels. Each experiment was performed at least 3 times. All values are represented as
the meansSEM of 3 experiments. *P<0.05, **P<0.01, as measured by the Mann-Whitney U-test (B), or the
Steel-Dwass test (C through F). AICAR indicates 5-aminoimidazole-4-carboxamide ribonucleotide; BSA, fatty
acid-free bovine serum albumin; Elovl6, elongation of long-chain fatty acid family member 6; H&E, hematoxylin-
eosin; HASMC, human aortic smooth muscle cells; KLF4, Kr€uppel-like factor 4; OA, oleic acid; PA, palmitic acid;
WT, wild-type C57BL/6 mice.
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as well as p53 and p21 mRNA levels observed in HASMC with
Elovl6 knockdown (Figure 6D and Figure S7D). These results
suggest that KLF4 mediates in part an induction of p21 and
p53 expression observed in HASMC with Elovl6 deﬁciency.
KLF4 Knockdown Affects SMC Marker Gene
Expression in a Context-Dependent Manner
KLF4 has been shown to act as potent repressor of VSMC gene
transcription in cultured VSMCs through multiple mechanisms
including the repression of function and expression of muscle-
restricted transcription coactivator myocardin.38-40 Thus, it is
anticipated that KLF knockdown enhances VSMC marker gene
expression. Unexpectedly, however, we found that mRNA
expression of SMa-actin and SM22a was signiﬁcantly reduced
in HASMC with KLF4 knockdown (Figure S8A). Nevertheless,
Western blot analysis revealed that the protein levels of
SMa-actin and SM22awere not changed in HASMC transfected
with siKLF4 (Figure S8B). The most likely explanation for these
apparently contradictory results would be that experimental
conditionsmay affect the role of KLF4 on SMC gene expression,
given that KLF4 only transiently binds to the SMC promoters at
an early time point after KLF4 induction.38 Indeed, we found
that siRNA-mediated Elovl6 or KLF4 knockdown increased
SMa-actin or SM22a expressions at an early time point
(8-24 hours after transfection of siRNA); however, Elovl6 or
KLF4 knockdown markedly suppressed SMC marker gene
expression 48 hours after transfection (Figure S8C).
AMPK Directly Activates KLF4 Expression in
VSMC In Vitro
To determine whether AMPK activates KLF4 expression, we
examined the effects of a pharmacological AMPK activator
(5-aminoimidazole-4-carboxamide ribonucleotide; AICAR) or
inhibitor (Compound C) on KLF4 protein expression. AICAR
signiﬁcantly induced KLF4 protein levels in a time-dependent
manner, and Compound C diminished this effect (Figure 6E). Of
importance, Compound C completely abrogated an increase in
KLF4 protein levels observed in HASMC with Elovl6 knockdown
(Figure 6F). In contrast, KLF4 knockdown had no effects on
phosphorylation of AMPK (Figure S9). Taken together, these
results identify KLF4 as a bona ﬁde direct target of AMPK.
AMPK Phosphorylation Is Induced by Oxidative
Stress
Toexplore themechanismsbywhichElovl6 deﬁciency leads toan
induction of AMPK phosphorylation in VSMC, we examined the
reactive oxygen species (ROS) production in Elovl6/ mice.
Immunohistochemistry revealed that nitrotyrosine immunoreac-
tivity, usedasamarker ofoxidative stress,was fairly detectable in
Elovl6/mice but poorly detectable in WT mice (Figure 7A). At
14 days after wire injury, however, nitrotyrosine immunore-
actvity was clearly enhanced in both WT and Elovl6/ mice
(Figure 7A). Furthermore, we found that siRNA knockdown of
Elovl6 induced ROS production as assessed by using
CM-H2DCFDAprobe inHASMC(Figure 7B). Inaddition,palmitate
induced ROS production, and oleate inhibited this palmitate-
induced ROS production in HASMC (Figure 7B). Quantitation
using a ﬂuorometric assay, which primarily detects production of
H2O2, showed that Elovl6 knockdown and exposure to palmitate
increased production of H2O2 in HASMC by 1.7- and 1.9-fold,
respectively, compared with controls (Figure 7C). To explore
whethermitochondria could be involved in ROS production, we
measured mitochondria-derived superoxide levels by using
mitoSOX ﬂuorescent probes (Life Technologies, Carlsbad, CA).
However, we could hardly detect the difference in signal
Figure 6. continued
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Figure 7. ROS generation induces phosphorylation of AMPK and KLF4 expression in VSMC. A,
Immunohistochemical staining with an antibody against nitrotyrosine in femoral artery sections
from Elovl6/ or WT mice. The nitrotyrosine-positive cells were signiﬁcantly increased in the
medial layer of the aorta of Elovl6/mice compared to WTmice before or after wire injury. Scale
bar=200 lm. B, Intracellular ROS production was detected using oxidant-sensitive ﬂuorogenic
probe CM-H2DCFDA in HASMC. The siRNA-mediated Elovl6 knockdown or stimulation with PA
(250 lmol/L) increased ROS levels in comparison with siGFP or BSA. Costimulation of OA
(250 lmol/L) signiﬁcantly reduced PA-induced ROS generation. Scale bar=200 lm. C, ﬂuoro-
metric assay showed increased H2O2 generation in HASMC transfected with Elovl6 siRNA (siGFP,
siElovl6: n=6) or treated with PA (BSA, PA, OA, PA+OA: n=6). D, Western blot analysis of AMPK and
KLF4 in HASMC treated with 100 lmol/L H2O2. Phosphorylation of AMPKwas normalized by total
AMPK protein amount, and KLF4 protein levels were normalized by b-actin levels. Relative protein
expression was expressed as a fold increase from themean level of the controls. Exposure to H2O2
(n=3per group) signiﬁcantly inducedphosphorylation of AMPKandKLF4expression. Costimulation
with catalase (1 unit, n=3 per group) signiﬁcantly reduced H2O2 induction of these expressions. E,
qRT-PCR for KLF4, SMa-actin, and SM22amRNA levels in HASMC treated with 100 lmol/L H2O2
for 24 hours (control: n=6; H2O2: n=8). KLF4 mRNA levels, normalized by mRNA levels of 36B4,
were signiﬁcantly increased, whereas SMa-actin and SM22a mRNA levels were decreased
by H2O2 treatment. F, Western blot analysis also showed that exposure of HASMC to H2O2
decreased protein expression of SMa-actin and SM22a, normalized by b-actin levels (control,
H2O2: n=6). Each experiment was performed at least 3 times. All values are represented as the
meansSEM of 3 experiments. *P<0.05, **P<0.01, as measured by the Tukey-Kramer test (C),
Steel-Dwass test (D), or Mann-Whitney U-test (E and F). AMPK indicates AMP-activated protein
kinase; BSA, fatty acid-free bovine serum albumin; CM-H2DCFDA, 5-(6)-chloromethyl-20,
70-dichlorodihydroﬂuorescein diacetate acetyl ester; Elovl6, elongation of long-chain fatty acid
family member 6; H&E, hematoxylin-eosin; H2O2, hydrogen peroxide; HASMC, human aortic
smooth muscle cells; KLF4, Kr€uppel-like factor 4; OA, oleic acid; PA, palmitic acid; ROS,
reactive oxygen species; SM22a, smooth muscle protein 22a; SMa-actin, smooth muscle
a-actin; WT, wild-type C57BL/6 mice.
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intensity among siElovl6-transfected HASMC, palmitate-treated
HASMC, and control cells, suggesting that excessive super-
oxide is not likely to be generated in mitochondria in either
siElovl6-transfected or palmitate-treated HASMC.
We found that exposure of HASMC to hydrogen peroxide
(H2O2 100 lmol/L) resulted in induced AMPK phosphoryla-
tion and subsequently increased KLF4 expression (Figure 7D).
Catalase, an antioxidant that eliminates H2O2, prevented
H2O2-induced AMPK phosphorylation and KLF4 expression in
HASMC (Figure 7D). Furthermore, exposure of HASMC to
H2O2 increased KLF4 mRNA and decreased SMa-actin and
SM22a mRNA levels (Figure 7E). Western blot analysis also
showed that exposure of HASMC to H2O2 decreased protein
levels of SMa-actin and SM22a (Figure 7F). These results
suggest that ROS is an important mediator for the induction of
AMPK phosphorylation and the resulting KLF4 expression in
Elovl6-deﬁcient VSMC.
Discussion
In the present study we examined the role of Elovl6-mediated
LCFA metabolism in the regulation of VSMC phenotypic
switching in vivo and in vitro. To summarize, results shown
here are depicted in Figure 8. Elovl6 deﬁciency causes an
increase in intracellular palmitate and a decrease in oleate,
both of which contribute to ROS production and promote
phosphorylation and activation of AMPK. As a consequence of
AMPK activation, KLF4 is induced to increase p53 and p21
expression, ACC is phosphorylated, and mTOR is dephospho-
rylated. Our ﬁndings strongly indicate the pivotal role of
Elovl6-driven fatty acid metabolism in the regulation of
proliferation and differentiation of VSMC, 2 pathophysiological
processes that determine VSMC phenotype.
One of the seminal ﬁndings in this study is that KLF4
expression is robustly induced in Elovl6/ mouse aorta and
VSMC with siRNA knockdown of Elovl6. Elovl6 siRNA-
transfected VSMC is characterized by reduced proliferation
and migration as well as reduced expression of VSMC
markers. More importantly, these changes are likely to be
at least partly ascribed to KLF4 induction because KLF4
knockdown mitigates activation of the cell cycle inhibitory
Figure 7. continued.
Figure 8. Schematic diagram of the molecular mechanisms for
phenotypic modulation of VSMC in Elovl6-deﬁcient VSMC. A
reduction in the expression of Elovl6 in VSMC induces change in
the fatty acid composition; C16 PA is increased, and C18 OA is
decreased, in vivo and in vitro. These changes in FA composition
induce ROS production that leads to AMPK activation, an increase
in KLF4, p53, and p21 expression, decreases in SMa-actin,
SM22a, and mTOR expression, and a decrease in ACC activity.
Thus, Elovl6-mediated derangement of FA composition in VSMC
induces phenotypic switching of VSMC. ACC indicates acetyl-CoA
carboxylase; AMPK, AMP-activated protein kinase; Elovl6, elon-
gation of long-chain fatty acid family member 6; FA, fatty acid;
KLF4, Kr€uppel-like factor 4; mTOR, mammalian target of
rapamycin; OA, oleic acid; PA, palmitic acid; ROS, reactive oxygen
species; SM22a, smooth muscle protein 22a; SMa-actin, smooth
muscle a-actin; VSMC, vascular smooth muscle cells.
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genes p53 and p21 in Elovl6-deﬁcient VSMC. These results
are consistent with the previous reports demonstrating that
KLF4 induces cell cycle arrest.38,41-44
Of note, induction of KLF4 expression by Elovl6 knockdown
is dependent on AMPK activation, based on the results that
Compound C, a speciﬁc inhibitor of AMPK, completely
abrogated KLF4 induction. Our data also indicate that KLF4
is required for AMPK-induced p21 expression. Collectively,
our results demonstrate that KLF4 is one of the primary genes
that regulate cellular response to AMPK activation.
It is notable that VSMC transfected with siElovl6 displays
downregulation of SMC marker gene expression along with
decreased proliferation and migration activities, given that the
loss of SMC marker gene expression is generally coupled with
the increased proliferation and migration during phenotypic
transition.2 Our ﬁndings that the AMPK/KLF4 axis plays a
central role in phenotypic transition in VSMC with Elovl6
knockdown prompt us to speculate that the phenotype of
Elovl6-deﬁcient VSMC may be relevant to cellular senescence-
associated phenotype. Cellular senescence is observed in
most mammalian cells in the setting of a variety of stresses
including alterations in intracellular metabolism.45 Emerging
evidence indicates that AMPK activation and resulting p53-
p21 axis activation promote senescent phenotype, the
hallmarks of which are the irreversible loss of proliferative
potential and acquisition of altered differentiated function.46
We found that Elovl6 knockdown induces apoptosis as
assessed by the activation of caspase 3/7 to some extent
(data not shown), suggesting that altered Elovl6-mediated
LCFA metabolism induces both apoptosis and perhaps a state
of senescence. Further work will be warranted to deﬁne such
previously unrecognized phenotypes.
A recent SMC lineage-tracing study demonstrates that
substantial numbers of macrophage-like cells within the
atherosclerotic plaques are derived from VSMC in apolipopro-
tein E (apoE)-knockout mice and in humans.8 In addition,
VSMC-speciﬁc conditional knockout of KLF4 results in
decreased lesion size, increased plaque stability, and a
marked reduction in the number of VSMC-derived macro-
phage-like cells. Of particular interest in that study, in addition
to an increase in macrophage and proinﬂammatory marker
expression, KLF4 is induced in response to cholesterol loading
in cultured VSMC. These observations led us to speculate that
KLF4 is activated by metabolic stress triggered by perturbed
intracellular lipid metabolism, such as cholesterol loading and
altered LCFA composition, and if so, the AMPK/KLF4 axis
plays a principal role in passing the metabolic stress on to the
machinery regulating the phenotype of VSMC. Furthermore,
the ﬁnding that an intracellular dysmetabolic state regulates
KLF4 expression might best be viewed as evidence indicating
that nutrient metabolism, cellular behavior, and cell cycle are
intimately interconnected.28
A key question is how Elovl6 deﬁciency within VSMC
results in a marked activation of AMPK. The classical view is
that AMPK, a highly conserved heterotrimer comprising an a-
catalytic subunit with bc-regulatory subunits, responds to a
reduction in the energy charge, switches off anabolic
pathways such as fatty acid, triglyceride, and cholesterol
synthesis, and switches on catabolic pathways that generate
ATP, such as fatty acid oxidation and glycolysis.24-26 However,
activation of AMPK in Elovl6-deﬁcient VSMC is not likely due
to reduced cellular ATP content because exposure of cultured
HASMC with palmitate recapitulated the response to Elovl6
knockdown. Thus, we propose that speciﬁc composition of
LCFA, rather than reducing energy charge, induces the
activation of AMPK in VSMC. In fact, Watt et al previously
showed that palmitate treatment induces AMPK activation in
L6 skeletal muscle myotubes in the absence of detectable
changes in free AMP and glycogen content,47 although
precise molecular mechanisms whereby palmitate induces
AMPK have not been described.
Our study newly identiﬁes ROS as an upstream effector that
induces AMPK activation in response to increased palmitate
availability. We previously showed that dysregulation of Elovl6-
mediated LCFA metabolism induces ROS production and
pulmonary ﬁbrosis.13 Similar ﬁndings were observed in the
present study, implying that ROS production in Elovl6-deﬁcient
cells is not cell type speciﬁc. We now demonstrate several lines
of evidence indicating the causative role of ROS production for
AMPK/KLF4 activation in Elovl6-deﬁcient VSMC: (1) ROS
production was increased in Elovl6/ mice and siElovl6-
transfected VSMC; (2) palmitate induced and oleate reduced
ROS production; and (3) exposure of VSMC to H2O2 recapit-
ulated the ﬁndings of Elovl6-deﬁcient VSMC, including an
increased phosphorylation of AMPK, elevation of KLF expres-
sion, and reduced VSMC gene expression. These data support
the accumulating evidence indicating that increased ROS
production in response to saturated LCFA overload plays a
critical role in the regulation of cellular function.48-51 Then,
what are the mechanisms by which ROS induces AMPK
activation? Although this question remains to be addressed, we
recently found that the expression of Sestrin 1 and 2, which
function as antioxidants or as AMPK activators in response to
metabolic stress,52 was increased in HASMC with Elovl6
knockdown. Future work should be warranted to identify the
mechanism of ROS generation and ROS-induced AMPK activa-
tion in Elovl6-deﬁcient VSMC.
Our results have potential clinical implications, especially
related to the vascular complications in type 2 diabetes and
obese subjects because previous studies showed that Elovl6
expression is transcriptionally induced by insulin and overnu-
trition through the action of the lipogenic transcription factor,
SREBP1c9,53 in hepatocytes. We found that PDGF-BB and
hypoxia efﬁciently increased Elovl6 gene expression in
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HASMC (Figures S3 and S10). Thus, it is tempting to
speculate that overnutrition-induced elevation of Elovl6
expression in VSMC may contribute to the development of
advanced atherosclerotic lesions and neointima by priming
the cells for enhanced mitogenic response.
Our ﬁndings that mTOR and p21 expression was pro-
foundly affected by Elovl6 knockdown seem to support the
concept that growth and cell division are coordinately
regulated to ensure that cells keep a fairly constant size.54
Our study further highlights the central role of AMPK not only
as a sensor for AMP/ATP levels but also as a sensor of
metabolic stress caused by change in lipid composition. There
has been a general consensus that AMPK activation directly
and indirectly (via TSC2 and Raptor) suppresses mTOR activity
to limit protein synthesis. Accordingly, our data corroborate
the notion that AMPK is a regulator of cellular proliferation
and protein synthesis by coordinating multiple cellular
processes to maintain energy homeostasis and normal
cellular function.
It is possible that activation of AMPK is expected to promote
preferential partitioning of intracellular fatty acids away from
esteriﬁcation toward oxidation. Thus, activation of AMPK could
be an endogenous protective mechanism to ameliorate
lipotoxic effects of palmitate leading to endoplasmatic retic-
ulum (ER) stress, inﬂammation, and insulin resistance55-57 in
Elovl6-deﬁcient VSMC. Further studies are needed to verify our
hypothesis that activation of AMPK/KLF4 signaling by loss of
Elovl6 is protective against atherosclerosis by using double
knockout mice of Elovl6 and apoE.
In summary, our study reveals a previously unrecognized
role of Elovl6-driven LCFA metabolism as an intracellular cue
for the regulation of VSMC phenotypic switching. Further-
more, we provide evidence for the role of LCFA composition
and ROS production in the activation of AMPK/KLF4 signaling
in VSMC. These ﬁndings indicate that strategies aimed at
Elovl6-driven LCFA metabolism and AMPK/KLF4 signaling
may represent a successful approach to limit atherosclerosis
and postangioplasty restenosis.
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Data S1. Supplemental Experimental Procedures  
Animals 
C57BL/6 strain (wild-type, WT) mice and Wistar rats were purchased from CLEA Japan Inc.. Elovl6-/- mice 
were kindly gifted from Dr. H. Shimano (Tsukuba University). These mice were intercrossed into Elovl6-/- or 
Elovl6-/+ mice. Littermates were genotyped by PCR. 
 
Human arterial tissue 
Eight human coronary artery sections, containing diffuse intimal thickening or apparently normal pathology, 
were obtained from patients with ischemic or non-ischemic heart disease. 
 
Tissue preparation and immunohistochemistry 
Following the induction of deep anesthesia, mice were killed and perfused via the left ventricle with phosphate 
buffered saline (PBS), followed by perfusion fixation with 10% formalin for 10 min. The right femoral artery 
was carefully harvested and embedded in paraffin. Human arterial tissues were obtained from patients at autopsy 
and tissue samples were fixed in formalin and embedded in paraffin. Each serial section (4-μm) was prepared 
for the histological analysis. 
Sections were deparaffinized in xylene and rehydrated prior to antigen retrieval by boiling in citrate buffer. 
Elovl6 (ABGENT, AP6524a, 1:50), SM-actin (Dako corp., M0851, 1:500), and Nitrotyrosine (Cell Signaling 
Technology, #9691, 1:50) staining was performed using the Vectastain Elite ABC kit (Vector Laboratories) 
according to the manufacturer’s instruction, with 3,3’-diaminobenzidine (DAB) as the chromogenic substrate. 
Sections were stained with hematoxylin and eosin (H&E) and elastica van Gieson (EVG) using standard 
procedures. The immunohistochemistry of artery cross-sections was examined by an image analysis 
 by guest on January 30, 2017
http://jaha.ahajournals.org/
D
ow
nloaded from
 
(WinROOF, Mitani Shoji Co.). In each artery, measurements of the intimal (I, tissue between the lumen and 
internal elastic lamina) and medial (M, tissue between the internal and external elastic lamina) areas were 
obtained, and the intimal/media area ratio (I/M ratio) was calculated1-3. Ki-67 (Thermo Scientific, SP6, 1:200) 
-positive cells were calculated as the number of cells that co-localized with 4', 6-diamidino-2-phenylindole 
(DAPI, Dojindo, 1:1000) in the neointimal thickening area of the femoral artery in mice. 
 
Balloon injury to the rat carotid artery 
The carotid artery of rats was injured with a balloon as described previously4. In brief, 8-week-old male Wister 
(n=12) rats weighing approximately 300 g were injured with a 2F balloon catheter (Edwards Lifesciences). The 
animals were euthanized 14 days after the balloon injury and the thoracic aorta was harvested. 
 
Cell culture 
Human aortic smooth muscle cells (HASMC) were purchased from Kurabo Ltd. HASMC were cultured at 
37°C in a 5% CO2 atmosphere in Humedia-SB2 medium supplemented with 5% fetal bovine serum (FBS), 0.5 
μg/ml of recombinant human epidermal growth factor (EGF), 2 μg/ml of recombinant human basic fibroblast 
growth factor (bFGF), 5 mg/ml of insulin, 50 mg/ml of gentamycin, and 50 μg/ml of amphotericin B. HASMC 
were used between passages 4 and 8 in these experiments. Serum-starved HASMC with 0.1% BSA (24 hours) 
were incubated in the presence or absence of BSA-conjugated palmitate or oleate (Sigma, 250 µM). Serum-
starved HASMC were also treated with 1 mM AICAR (Toronto Research Chemicals) or 10 μM Compound 
C (Merck). Cells were also treated with vehicle as control, TGF- (Roche) or PDGF-BB (R＆D systems). 
HASMC was treated with 100 μM H2O2 (Wako) in the presence or absence of 1 unit catalase (Merck Millipore). 
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RNA isolation and quantitative real-time reverse transcription (qRT-PCR) 
Total RNA was extracted from the mouse aorta and cultured HASMC using ISOGEN regent (Takara Bio) 
according to the manufacturer’s protocol. One microgram of RNA was used for reverse transcription with the 
RNA LA PCR Kit (Takara Bio) and qRT-PCR analysis was performed using the THUNDERBIRD SYBR qPCR 
Mix (TOYOBO) according to the manufacturers’ protocols. QPCR was carried out using a MX3000P 
quantitative system (Stratagene). All primer sequences are shown in Supplemental Table I and Table II. Each 
experiment used three samples and was performed three times.  
 
Construction of siRNA oligonucleotides and transfection 
siRNA oligonucleotides (human siElovl6: CUU UUG AAC AGA AGA GUA AAU, human sip21: CGA CUG 
UGA UGC GCU AAU G, CCU AAU CCG CCC ACA GGA A, CGU CAG AAC CCA UGC GGC A, AGA 
CCA GCA UGA CAG AUU U, human siKLF4: CCA GAG GAG CCC AAG CCA ATT, siGFP: GUU CAG 
CGU GUC CGG CGA GTT) were purchased from BONAC Corporation and transfected with Lipofectamine 
RNAiMAX Regent (Invitrogen) according to the manufacturer’s protocol. siGFP concentration used was 50 
nM, which has little, if any, off-target effects5. In order to effectively inhibit the four transcript variants of human 
p21 expression, we used four sequences of p21 siRNA that were mixed in equal amounts. 
 
[3H]-thymidine uptake 
The uptake of radiolabeled [3H]-thymidine was assayed as described previously6, with some modifications. 
Briefly, HASMC were seeded on 24-well plates (2.5×104 cells/well) and cultured for 24 hours in Hu-media 
containing 5% FBS. These cells were treated with each adenovirus or siRNA followed by serum-starvation 
(0.5% FBS) for 24 hours. Serum-starved HASMC with 0.1% BSA (24 hours) were also treated with BSA-
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conjugated palmitate or oleate (250 µM each) for 24 hours. The cells were incubated with [3H]-thymidine (1 
mCi/well; Perkin Elmer) in a 5% CO2 atmosphere at 37°C. After a 5 hours incubation, the cells were washed 
with ice-cold PBS and the reaction was stopped by the addition of ice-cold 5% trichloroacetic acid (TCA) for 
30 min. The cells were digested in 0.5 M NaOH for 1 hour and aliquots were used to determine the radioactive 
count with a scintillator counter (Aloca LSC3000). 
 
Scratch wound healing assay 
The measurement of migration by the scratch mobility assay was performed as described previously7. Briefly, 
HASMC transduced with the adenovirus or siRNA were seeded on 6-well plates. After 24 hours, a single 
uniform scratch was made on the monolayer in each well using a sterile 200-l pipette tip. The monolayer was 
rinsed three times and placed in Hu-media with 0.5% FBS. Phase contrast images were captured immediately 
and after 8 hours or 24 hours incubation, and a digital image of the scar was taken at a magnification of ×40. 
Each experiment was performed in duplicate and three independent assays were performed (n=6). 
 
Boyden chamber assay 
Boyden chamber assay was performed as previously described7. Briefly, HASMC which were transfected with 
siElovl6 or siGFP for 48 h were plated (2.5×104/well) in the upper chamber of transwells (6.5-mm diameter, 
5.0-µm pore size polycarbonate membrane, Neuro Probe). The cells were returned to the 37°C 5% CO2 
incubator for 4 h, rinsed with PBS, and cells remaining at the top of the polycarbonate membrane were removed. 
The cells that had migrated through pores to the lower surface were fixed in methanol, stained with a Diff-Quick 
kit (Sysmex). Membranes were mounted on microslides and four random microscopic fields per well were 
quantified. Each experiment was conducted in duplicate and three separate experiments were performed (n=6-
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7). 
 
Fatty acid composition 
Lipids from the mouse aorta and HASMC were extracted using the Bligh and Dyer method as described 
previously8. Briefly, arterial tissues and cells were extracted with chloroform/methanol (1:2, v/v) solution. In 
order to break monophase, 1 M NaCl solution and chloroform were then added, and incubated on ice for 10 min. 
After centrifugation at 2,000 rpm for 5 min, the aqueous solution was discarded and the chloroform phase was 
transferred to a test tube. The chloroform phase was evaporated using nitrogen gas, and the lipids obtained were 
subjected to a fatty acid composition analysis at an external laboratory (SRL Inc.). 
 
Western blot analysis 
Tissue samples and cells were homogenized on ice in RIPA buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 
1% NP-40, 1% sodium deoxycholate, 0.1% SDS, and containing complete mini and phosSTOP solution 
(Roche)). The mixture was centrifuged at 15,000 rpm for 30 min and the supernatant was subjected to SDS-
PAGE. Protein concentrations were determined by the Bradford method using a colorimetric assay (Bio-Rad). 
Western blot analysis was performed according to standard procedures using the following primary antibodies: 
rabbit monoclonal phospho-AMPK (Cell Signaling Technology, #2535, 1:250), AMPK (Cell Signaling 
Technology, #2603, 1:500), ACC (Cell Signaling Technology, #3676, 1:500), phospho-mTOR (Cell Signaling 
Technology, #5536, 1:250), mTOR (Cell Signaling Technology, #2983, 1:500), p21 (Cell Signaling Technology, 
#2947, 1:500), KLF4 (Cell Signaling Technology, #4038, 1:250), β-actin (Cell Signaling Technology, #4970, 
1:500), and rabbit polyclonal phospho-ACC (Cell Signaling Technology, #3661, 1:250), phospho-p53 (Cell 
Signaling Technology, #9284, 1:250), SM-actin (Dako corp., M0851, 1:100), SM22 (Abcam, ab14106, 
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1:1000) and mouse polyclonal p53 (Santa Cruz Biotechnology, #Sc-126, 1:100). Antigens were revealed by 
Immobilon Western HRP Substrate (Millipore) after an incubation with horseradish peroxidase-conjugated anti-
rabbit or mouse IgG. The density of a band was quantified using ImageJ software. 
 
Preparation of fatty acid solution 
Palmitate was conjugated to fatty acid-free bovine serum albumin at a 3.5:1 molar ratio by dissolving them in 
ethanol and mixing with an aqueous BSA solution (BSA in phosphate-buffered saline, PBS) at 37°C until 
homogeneous. They were then passed through a 0.2-μM filter. 
 
Estimation of ROS generation 
Intracellular ROS levels were detected with the oxidant-sensitive fluorogenic probes 5-(and 6)-chloromethyl-
2’,7’-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA, Invitrogen). siRNA-transfected 
HASMC was incubated with 10 µM CM-H2DCFDA in serum-free medium for 30 min at 37°C. Otherwise, the 
cells were incubated in the presence or absence of palmitic acid and oleic acid for 15 min after 30 min incubation 
of 10 µM CM-H2DCFDA. After incubation at 37°C, fluorescence was detected. 
 
Ethical approval 
Human coronary artery tissues with atherosclerosis were obtained from patients at autopsy with written 
informed consent of their family at Gunma University Hospital. This protocol was approved by the Institutional 
Review Board at the Gunma University Hospital. 
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Figure S1. Expression of Elovl6 in intimal thickening lesions of the human coronary artery. 
 
 
 
 
 
 
 
 
 
 
 
 
Eight human coronary artery sections, containing diffuse intimal thickening or apparently normal pathology, 
from a patient with ischemic or non-ischemic heart disease were stained with H&E, EVG, and with antibodies 
against Elovl6 and SM-actin. The expression of Elovl6 was co-localized with SM-actin in the thin medial 
layer in a normal coronary artery, and increased in intimal thickening lesions of human coronary artery. Scale 
bar = 200 μm. H&E, hematoxylin-eosin; EVG, elastica van Gieson; Elovl6, elongation of long-chain fatty acid 
family member 6; SM-actin, smooth muscle alpha-actin. 
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Figure S2. Adenovirus-mediated overexpression of Elovl6 in HASMC. 
 
 
Western blot analysis with an anti-flag M2 antibody in HASMC transduced with Ad-Elovl6 (n=6) or Ad-LacZ 
(n=6). Flag-tagged Elovl6 was markedly up-regulated in HASMC infected with Ad-Elovl6. β-actin was 
measured as an internal control. This experiment was performed at least three times. Values are represented as 
the means ± SEM of three experiments. *p<0.05, **p<0.01, as measured by the Mann-Whitney U-test. HASMC, 
human aortic smooth muscle cells; Ad-LacZ, adenoviral vector encoding lacZ gene; Ad-Elovl6, adenoviral 
vector encoding elongation of long-chain fatty acid family member 6 gene. 
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Figure S3. Induction of Elovl6 expression by PDGF-BB in HASMC.  
 
qRT-PCR for Elovl6 mRNA in HASMC. PDGF-BB induced Elovl6 mRNA levels in a dose-dependent manner 
(control, TGF-β, PDGF-BB: n=6). 36B4 mRNA levels were measured as internal controls. This experiment was 
performed at least three times. Values are represented as the means ± SEM of three experiments. *p<0.05, as 
measured by the Tukey-Kramer test. Elovl6, elongation of long-chain fatty acid family member 6; HASMC, 
human aortic smooth muscle cells; PDGF-BB, platelet-derived growth factor-BB, TGF-β, transforming growth 
factor-beta. 
 by guest on January 30, 2017
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Figure S4. Overexpression of Elovl6 modulated cell cycle regulators in HASMC.  
 
 
(A, B) qRT-PCR for SM-actin and SM22 mRNA levels (A) and western blot assay for protein levels (B) in 
HASMC infected with Ad-Elovl6 (n=6) or Ad-LacZ (n=5) for 48 hours. Overexpression of Elovl6 increased the 
SM22α and SMα-actin mRNA and protein levels in HASMC. (C) qRT-PCR for the expression of p53, p21 and 
mTOR mRNA in HASMC infected with Ad-Elovl6 (n=6) or Ad-LacZ (n=7) for 48 hours. p21 mRNA levels 
were decreased while mTOR mRNA levels were increased by Elovl6 overexpression. (D) Western blot analysis 
of AMPK in HASMC infected with Ad-Elovl6 (n=6) or Ad-LacZ (n=6) for 48 hours. Overexpression of Elovl6 
suppressed phosphorylation of AMPK. 36B4 for qRT-PCR and β-actin for western blot were measured as an 
internal control. Western blot data for the phosphorylation of AMPK were normalized by total AMPK in the 
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same samples, and expressed as a fold increase from the mean level of control group. Each experiment was 
performed at least three times. All values are represented as the means ± SEM of three experiments. *p<0.05, 
**p<0.01, as measured by the Mann-Whitney U-test. SM-actin, smooth muscle alpha-actin; SM22, smooth 
muscle protein 22-alpha; HASMC, human aortic smooth muscle cells; Ad-LacZ, adenoviral vector encoding 
lacZ gene; Ad-Elovl6, adenoviral vector encoding elongation of long-chain fatty acid family member 6 gene; 
mTOR, mammalian target of rapamycin; AMPK, AMP-activated protein kinase. 
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Figure S5. Elovl6-overexpression altered the fatty acid composition in HASMC.  
 
 
(A) Fatty acid composition of the neutral lipid extract from HASMC infected with Ad-Elovl6 (n=5) or Ad-LacZ 
(n=4) for 48 hours. The adenovirus-mediated overexpression of Elovl6 decreased the relative amounts of 
palmitate (C16:0) and palmitoleate (C16:1 n-7), and increased those of oleate (C18:1 n-9) more than the 
infection with Ad-LacZ. (B) qRT-PCR for SCD1 mRNA in HASMC infected with Ad-Elovl6 (n=6) or Ad-LacZ 
(n=5). The overexpression of Elovl6 did not change SCD1 mRNA levels. 36B4 was measured as an internal 
control. mRNA levels in the Ad-LacZ control group were normalized to a value of 1, while those in Ad-Elovl6 
cells are shown relative to the control level. Each experiment was performed at least three times. All values are 
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represented as the means ± SEM of three experiments. *p<0.05, **p<0.01, as measured by the Mann-Whitney 
U-test. HASMC, human aortic smooth muscle cells; Ad-LacZ, adenoviral vector encoding lacZ gene; Ad-Elovl6, 
adenoviral vector encoding elongation of long-chain fatty acid family member 6 gene; SCD1, stearoyl-CoA 
desaturase 1. 
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Figure S6. Changes of Elovl6 expression in HASMC affect KLF4 expression. 
 
(A) Western blot analysis of KLF4 expression in HASMC transfected with Elovl6 (n=6) or GFP siRNA (n=6). 
KLF4 protein levels were significantly increased by the siRNA-mediated knockdown of Elovl6. (B) qRT-PCR 
analysis for KLF4 mRNA in HASMC with siRNA-mediated knockdown of Elovl6 (siGFP: n=7 ; siElovl6 : 
n=6). (C) Western blot analysis of KLF4 in HASMC infected with Ad-Elovl6 (n=6) or Ad-LacZ (n=6) for 48 
hours. Overexpression of Elovl6 significantly decreased KLF4 protein levels. (D) qRT-PCR for KLF4 mRNA 
in HASMC infected with Ad-Elovl6 (n=6) or Ad-LacZ (n=6) for 48 hours. KLF4 mRNA levels were decreased 
by Elovl6 overexpression. (E) qRT-PCR for KLF4 mRNA in HASMC treated with fatty acids. The PA (C16:0) 
treatment significantly increased the KLF4 mRNA levels, whereas the OA (C18:1n-9) treatment inhibited this 
induction (BSA: n=8; PA, OA, PA + OA: n=7). 36B4 for qRT-PCR and β-actin for western blot were measured 
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as an internal control. Each experiment was performed at least three times. All values are represented as the 
means ± SEM of three experiments. *p<0.05, **p<0.01, as measured by the Mann-Whitney U-test (A-D) or 
Tukey-Kramer test (E). KLF4, krüppel-like factor 4; HASMC, human aortic smooth muscle cells; Ad-LacZ, 
adenoviral vector encoding lacZ gene; Ad-Elovl6, adenoviral vector encoding elongation of long-chain fatty 
acid family member 6 gene; PA, palmitic acid; OA, oleic acid; BSA, fatty acid-free bovine serum albumin. 
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Figure S7. Depletion of KLF4 affects cell cycle regulators and proliferation in HASMC with or without 
Elovl6 knockdown.  
 
 
(A, B) Western blot analysis (A) or qRT-PCR (B) of KLF4 expression in HASMC transfected with KLF4 (n=6) 
or GFP siRNA (n=5). KLF4 expression was significantly decreased by the siRNA-mediated knockdown of 
KLF4. (C) [3H]-thymidine uptake assay in HASMC transfected with Elovl6, KLF4 or GFP siRNA in the 
presence or absence of 1mM AICAR. Concomitant treatment of siKLF4 and siElovl6 partially reversed 
siElovl6-triggered inhibition of VSMC proliferation (siGFP, siElovl6, siKLF4: n=6; siElovl6 + siKLF4: n=7; 
AICAR: n=5). (D) Effects of KLF4 gene silencing on Elovl6 siRNA-induced cell cycle regulatory proteins in 
HASMC by qRT-PCR. Elovl6 depletion-induced expression of p53 and p21 was cancelled by the siRNA-
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mediated knockdown of KLF4 (siGFP, siElovl6: n=6; siGFP or siElovl6 + siKLF4: n=7). Each experiment was 
performed at least three times. All values are represented as the means ± SEM of three experiments. *p<0.05, 
**p<0.01, as measured by the Mann-Whitney U-test (A, B) or Tukey-Kramer test (C, D). KLF4, krüppel-like 
factor 4; HASMC, human aortic smooth muscle cells; AICAR, 5-aminoimidazole-4-carboxamide 
ribonucleotide; Elovl6, elongation of long-chain fatty acid family member 6; VSMC, vascular smooth muscle 
cells. 
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Figure S8. KLF4 knockdown affects SMC marker gene expression in a context-depend manner.  
 
 
(A, B) qRT-PCR for SM-actin and SM22 mRNA (A) and western blot assay for protein (B) in HASMC 
transfected with KLF4. SM-actin and SM22 mRNA levels were significantly decreased, but protein levels 
were not changed by siRNA-mediated knockdown of KLF4 (siGFP: n=7; siKLF4: n=8). 36B4 for qRT-PCR 
and β-actin for western blot were measured as an internal control. (C) qRT-PCR for the time-course of SM-
actin or SM22mRNA levels, normalized by mRNA levels of 36B4, in HASMC transfected with siRNA 
targeting Elovl6 or KLF4. siRNA-mediated Elovl6 or KLF4 knockdown increased SM-actin or 
SM22expressions at an early time (8-24h), however, Elovl6 or KLF4 knockdown markedly suppressed SMC 
marker gene expressions 48 h after transfection (siGFP, siElovl6, siKLF4 : n=7 ; siElovl6 + siKLF4 : n=7). Each 
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experiment was performed at least three times. All values are represented as the means ± SEM of three 
experiments. *p<0.05, **p<0.01, as measured by the Mann-Whitney U-test (A, B) or Tukey-Kramer test (C). 
SM-actin, smooth muscle alpha-actin; SM22, smooth muscle protein 22-alpha; HASMC, human aortic 
smooth muscle cells; KLF4, krüppel-like factor 4; Elovl6, elongation of long-chain fatty acid family member 
6; SMC, smooth muscle cell. 
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Figure S9. KLF4 knockdown had no effects on phosphorylation of AMPK. 
 
 
Western blot analysis of AMPK phosphorylation in HASMC transfected with KLF4 (n=6) or GFP siRNA (n=5). 
Phosphorylation of AMPK was not changed by siRNA-mediated knockdown of KLF4. β-actin was measured 
as an internal control. This experiment was performed at least three times. All values are represented as the 
means ± SEM of three experiments, measured by the Mann-Whitney U-test. AMPK, AMP-activated protein 
kinase; HASMC, human aortic smooth muscle cells; KLF4, krüppel-like factor 4. 
 
 
 
 by guest on January 30, 2017
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Figure S10. Induction of Elovl6 expression by hypoxic stress in HASMC.  
 
 
qRT-PCR for Elovl6 mRNA in HASMC. Hypoxic stress markedly induced Elovl6 mRNA levels, normalized 
by mRNA levels of 36B4, in a time-dependent manner (control, hypoxia: n=6). This experiment was performed 
at least three times. Values are represented as the means ± SEM of three experiments. *p<0.05, as measured by 
the Tukey-Kramer test. Elovl6, elongation of long-chain fatty acid family member 6; HASMC, human aortic 
smooth muscle cells. 
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Table S1. Human primer sequences used for qRT-PCR  
   
Target  
(Human) 
Sense Anti-sense 
Elovl6 5’-CGAGAATGAAGCCATCCAAT-3’ 5’-CCCGCAAGGCATAGTAAGAG-3 
SCD1 5’-CCACCGCTCTTACAAAGCTC-3’ 5’-TAGTTGTGGAAGCCCTCACC-3 
SM-actin 5’-ATGAGGGCTATGCCTTGCCC-3’ 5’-CCCGATGAAGGATGGCTGGA-3’ 
SM22 5’-AACAGCCTGTACCCTGATGG-3’ 5’-ATGACATGCTTTCCCTCCTG-3’ 
p53 5’-GTGGAAGGAAATTTGCGTGT-3’ 5’-TCTGAGTCAGGCCCTTCTGT-3 
p21 5’-GAGCGATGGAACTTCGACTT-3 5’-GGCGTTTGGAGTGGTAGAAA-3 
mTOR 5’-AGTGGACCAGTGGAAACAGG-3 5’-TCCGGCTGCTGCTGTAGCTTATT-3 
KLF4 5’-ACCCTGGGTCTTGAGGAAGT-3 5’-ATGTGTAAGGCGAGGTGGTC-3 
36B4 
5’-ATCCCTGACGACGCACCGCCGTGA-
3 
5’-TGCATCTGCTTGGAGCCCACGTT-3 
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Table S2. Mouse primer sequences used for qRT-PCR  
   
Target  
(Mouse) 
Sense Anti-sense 
Elovl6 5’-CCCGAACTAGGTGACACGAT-3’ 5’-TACTCAGCCTTCGTGGCTTT-3’ 
SCD1 5’-GCTGGGCAGGAACTAGTGAG-3’ 5’-GGTAGGGAGGATCTGGAAGC-3’ 
SM-actin 5’-AGACAGCTATGTGGGGGATG-3’ 5’-GAAGGAATAGCCACGCTCAG-3’ 
SM22 5’-TCCAGTCCACAAACGACCAAGC-3’ 5’-GAATTGAGCCACCTGTTCCATCTG-3’ 
p53 5’-ATCTGGACGACAGGCACACT-3’ 5’-CTTCGGGTAGCTGGAGTGAG-3’ 
p21 5’-GTCCAATCCTGGTGATGTCC-3’ 5’-CAGGGCAGAGGAAGTACTGG-3’ 
mTOR 5’-CATCCCCAAGGTGCTACAGT-3’ 5’-CAAACCACAGGGTGAGGACT-3’ 
KLF4 5’-CAGCTTCATCCTCGTCTTCC-3’ 5’-CGGGACTCAGTGTAGGGGTA-3’ 
36B4 
5’-ATCCCTGACGACGCACCGCCGTGA-
3 
5’-TGCATCTGCTTGGAGCCCACGTT-3 
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